Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China flag China · Delayed Price · Currency is CNY
24.58
-0.78 (-3.08%)
At close: Jul 16, 2026

SHE:300937 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
314.96409.36386.88374.86457.82153.78
Short-Term Investments
-9.274.120.83--
Trading Asset Securities
130.21-1.547-
Cash & Short-Term Investments
445.17418.64392.5379.69464.82153.78
Cash Growth
26.85%6.66%3.37%-18.32%202.27%34.62%
Accounts Receivable
382.27210.47229196.54146.2657.75
Other Receivables
62.0643.6485.1867.6215.9325.6
Receivables
444.32254.11314.18264.16162.1883.35
Inventory
487.54575.19522.59561.24446.78468.23
Other Current Assets
185.46154.64142.38171.35190.01126.33
Total Current Assets
1,5621,4031,3721,3761,264831.68
Property, Plant & Equipment
143.17143.75161.8154.05164.95174.76
Long-Term Investments
70.2961.4141.2328.2522.421.58
Goodwill
13.7113.7118.7116.4716.362.52
Other Intangible Assets
41.4143.0248.0346.4350.6542.06
Long-Term Deferred Tax Assets
40.3736.9827.3415.238.863.69
Long-Term Deferred Charges
19.5121.132.8243.9213.765.34
Other Long-Term Assets
--1.576.2750.83105.43
Total Assets
1,8911,7231,7031,6871,5921,187
Accounts Payable
599.59417.41333.22359.66370.54184.1
Accrued Expenses
11.2923.3432.2131.9822.1910.98
Short-Term Debt
334.84324.17372.32320.74235.84119.36
Current Portion of Leases
-6.536.774.25.244.7
Current Income Taxes Payable
21.4119.646.144.997.871.19
Current Unearned Revenue
47.7560.7849.8253.5778.8529.77
Other Current Liabilities
56.3152.2437.8925.9832.1827.9
Total Current Liabilities
1,071904.11838.35801.12752.7378
Long-Term Leases
3.44.049.764.692.545.75
Long-Term Unearned Revenue
4.274.354.6856.326.1
Long-Term Deferred Tax Liabilities
10.2510.9813.0813.3410.079.29
Other Long-Term Liabilities
0.470.470.356.88--
Total Liabilities
1,090923.95866.22831.02771.64399.13
Common Stock
95.6795.6795.6795.6795.6795.67
Additional Paid-In Capital
474474474.01474.01475.62475.56
Retained Earnings
248.42251.14273.55284.55244.15202.28
Comprehensive Income & Other
-----1.5-
Total Common Equity
818.09820.81843.23854.22813.94773.51
Minority Interest
-16.73-22.21-6.311.826.0314.43
Shareholders' Equity
801.36798.6836.93856.04819.98787.94
Total Liabilities & Equity
1,8911,7231,7031,6871,5921,187
Total Debt
338.24334.74388.85329.63243.62129.8
Net Cash (Debt)
106.9383.893.6550.06221.2123.98
Net Cash Growth
811.22%2200.11%-92.72%-77.37%822.60%-67.68%
Net Cash Per Share
1.150.880.050.522.320.26
Filing Date Shares Outstanding
95.6795.6795.6795.6795.6795.67
Total Common Shares Outstanding
95.6795.6795.6795.6795.6795.67
Working Capital
491.3498.46533.3575.32511.1453.68
Book Value Per Share
8.558.588.818.938.518.09
Tangible Book Value
762.97764.07776.49791.32746.94728.93
Tangible Book Value Per Share
7.987.998.128.277.817.62
Buildings
-116.62116.61116.57118.19117.76
Machinery
-97.7294.9682.3181.9978.87
Construction In Progress
-0.150.52.211.84-